Q2 2026 Holdings
Filed 2026-08-17 | 114 holdings | $605.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $134.0M | 1,886,236 | 22.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $95.7M | 3,228,144 | 15.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.3M | 242,029 | 7.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $26.8M | 774,501 | 4.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $20.5M | 256,603 | 3.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $18.5M | 365,386 | 3.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $14.8M | 111,334 | 2.4% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $14.2M | 770,765 | 2.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $12.9M | 110,393 | 2.1% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $11.9M | 433,147 | 2.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $10.7M | 4,347,826 | 1.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.1M | 118,240 | 1.7% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.9M | 1,504,400 | 1.6% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $9.8M | 80,000 | 1.6% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $8.6M | 246,606 | 1.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $7.9M | 117,067 | 1.3% |
| Xencor Inc(XNCR) | COM | 98401F105 | $7.8M | 368,305 | 1.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $7.8M | 220,126 | 1.3% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $7.4M | 284,430 | 1.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.1M | 28,826 | 1.2% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $7.0M | 148,647 | 1.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.3M | 64,723 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $5.7M | 147,510 | 0.9% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.6M | 308,007 | 0.9% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.6M | 45,400 | 0.9% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $5.6M | 1,001,373 | 0.9% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $4.3M | 1,330,500 | 0.7% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $4.1M | 1,085,398 | 0.7% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $4.0M | 610,785 | 0.7% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $3.8M | 159,118 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $3.3M | 178,222 | 0.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.2M | 86,664 | 0.5% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $3.2M | 11,869 | 0.5% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $3.1M | 403,545 | 0.5% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.9M | 136,016 | 0.5% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $2.9M | 736,077 | 0.5% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $2.7M | 4,973 | 0.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $2.5M | 7,540 | 0.4% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $2.4M | 348,265 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.1M | 56,900 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.1M | 33,300 | 0.3% |
| Savara Inc(SVRA) | COM | 805111101 | $1.9M | 309,103 | 0.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.8M | 381,169 | 0.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $1.8M | 29,800 | 0.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $1.7M | 16,252 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.6M | 77,930 | 0.3% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.5M | 317,600 | 0.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.4M | 26,800 | 0.2% |
| Leonabio Inc(LONA) | COM | 04746L203 | $1.4M | 154,153 | 0.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.4M | 37,865 | 0.2% |